Evogene Ltd. | Cash Flow
Fiscal year is January-December. All values ILS Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
32,045.20
51,976.60
66,876.30
75,209.10
74,953.80
74,824.60
Depreciation, Depletion & Amortization
7,370.60
8,045.10
9,452.70
8,748.50
7,715.50
7,262.40
Other Funds
595.60
683.20
975.20
1,800.40
471.20
13,633.20
Funds from Operations
10,496.50
28,499.50
33,300.20
52,318.50
56,591.20
53,928.90
Changes in Working Capital
8,525.70
3,319.60
14,903.70
7,431.90
705.00
578.80
Net Operating Cash Flow
19,022.10
31,819.10
48,203.90
44,886.70
57,296.20
54,507.80
Capital Expenditures
5,822.10
12,749.10
7,789.90
3,101.70
2,122.20
Sale of Fixed Assets & Businesses
-
-
-
19.20
-
Purchase/Sale of Investments
4,645.40
284,265.30
71,639.60
18,545.10
56,958.10
Net Investing Cash Flow
10,467.60
300,591.60
63,849.70
15,462.60
54,835.90
Net Financing Cash Flow
286,623.80
9,536.80
174.80
2,514.40
2,927.90
Net Change in Cash
256,968.10
322,809.60
15,754.60
26,813.80
715.80
Free Cash Flow
24,844.20
44,568.30
55,993.80
47,988.40
59,418.40
Change in Capital Stock
287,219.40
10,220.00
1,150.00
714.00
2,456.70
Exchange Rate Effect
166.00
64.40
66.00
96.00
248.20
Other Uses
-
3,577.20
-
-
-
About Evogene
View Profile
